Spots Global Cancer Trial Database for cancer of the prostate
Every month we try and update this database with for cancer of the prostate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers | NCT06363266 | Cancer of the P... Anxiety | TEMPO Active Monitori... | 18 Years - | St. Mary's Research Center, Canada | |
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| Maintaining Suppression of Testosterone With Transdermal Estradiol Gel | NCT02349386 | Cancer of the P... | BHR-200 (0.36% ... Placebo | 18 Years - | BHR Pharma, LLC | |
| Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | NCT00142506 | Prostate Cancer Erectile Dysfun... | sildenafil citr... placebo tablets... | - | Memorial Sloan Kettering Cancer Center | |
| A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer | NCT00564928 | Prostate Cancer Prostatic Neopl... Cancer of the P... | IPI-504 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences | |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study | NCT02939456 | Cancer of the P... | Magnetic Resona... | 18 Years - | University Hospitals of North Midlands NHS Trust | |
| A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer | NCT00564928 | Prostate Cancer Prostatic Neopl... Cancer of the P... | IPI-504 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study | NCT02355054 | Cancer of the P... | C-11 Choline PE... | 18 Years - | Washington University School of Medicine | |
| MR-simulation in Radiotherapy for Prostate Cancer | NCT03238170 | Cancer of the P... | MRI scan | 18 Years - | Guy's and St Thomas' NHS Foundation Trust | |
| Maintaining Suppression of Testosterone With Transdermal Estradiol Gel | NCT02349386 | Cancer of the P... | BHR-200 (0.36% ... Placebo | 18 Years - | BHR Pharma, LLC | |
| CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution | NCT00643994 | Prostate Cancer Prostatic Cance... Prostate Neopla... Prostatic Neopl... Cancer of the P... | CyberKnife Ster... | 18 Years - | Accuray Incorporated | |
| Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) | NCT02319837 | Hormone Sensiti... Prostate Cancer Cancer of the P... | Enzalutamide Placebo (No lon... Leuprolide Open... | 18 Years - | Pfizer | |
| Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ System | NCT02879851 | Cancer of the P... | 18 Years - | Hospices Civils de Lyon | ||
| Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance | NCT00744549 | Cancer of the P... Prostate Cancer Prostatic Neopl... | Lycopene, Vitam... Placebo | 18 Years - | University Health Network, Toronto | |
| Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer | NCT00844792 | Cancer of the P... Prostate Cancer Prostatic Neopl... | Lycopene, Vitam... Placebo | 18 Years - | University Health Network, Toronto | |
| Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate | NCT00915122 | Adenocarcinoma ... | Dose Escalated ... | - 80 Years | University Health Network, Toronto | |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors | NCT02957357 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | - | Alliance Foundation Trials, LLC. | ||
| Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer | NCT03285048 | Cancer of the P... Cancer | Cognitive Remed... | 18 Years - | Yale University | |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer | NCT03561220 | Prostate Cancer | Standard of Car... Standard of Car... Proton Arm 1: S... Proton Arm 2: H... | 30 Years - 85 Years | University of Florida | |
| A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors | NCT02225262 | Prostate Cancer Cancer of the P... Prostate Neopla... | CyberKnife Radi... | 21 Years - | Community Cancer Center, Normal, Illinois | |
| Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer | NCT00969202 | Prostate Cancer | Stereotactic Ra... | 18 Years - 99 Years | San Diego Radiosurgery | |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | NCT02564120 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | 35 Years - 80 Years | UNC Lineberger Comprehensive Cancer Center | ||
| Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer | NCT02079025 | Prostatic Neopl... Prostate Cancer Cancer of the P... | High-resolution... Standard ultras... | 40 Years - 79 Years | Exact Imaging | |
| A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | NCT00134706 | Prostate Cancer | Docetaxel Carboplatin | 18 Years - | Dana-Farber Cancer Institute | |
| European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up | NCT04017325 | Cancer of the P... | no intervention... | 18 Years - | Steba Biotech S.A. | |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | NCT00257478 | Prostate Cancer Cancer of Prost... Prostatic Cance... Cancer of the P... | YM155 | 18 Years - | Astellas Pharma Inc | |
| Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate | NCT00915122 | Adenocarcinoma ... | Dose Escalated ... | - 80 Years | University Health Network, Toronto | |
| Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer | NCT02578940 | Cancer of the P... | 18F-Fluciclovin... | 18 Years - | Blue Earth Diagnostics | |
| MR-simulation in Radiotherapy for Prostate Cancer | NCT03238170 | Cancer of the P... | MRI scan | 18 Years - | Guy's and St Thomas' NHS Foundation Trust | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy | NCT00241475 | Prostate Cancer | Gefitinib | 18 Years - | AstraZeneca | |
| Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer | NCT02578940 | Cancer of the P... | 18F-Fluciclovin... | 18 Years - | Blue Earth Diagnostics | |
| Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | NCT00142506 | Prostate Cancer Erectile Dysfun... | sildenafil citr... placebo tablets... | - | Memorial Sloan Kettering Cancer Center | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance | NCT00744549 | Cancer of the P... Prostate Cancer Prostatic Neopl... | Lycopene, Vitam... Placebo | 18 Years - | University Health Network, Toronto | |
| Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose | NCT02212548 | Cancer of the P... | PEG Hydrogel (S... | - | Royal North Shore Hospital | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | NCT02003924 | Nonmetastatic C... Prostate Cancer Cancer of the P... | Enzalutamide Placebo | 18 Years - | Pfizer | |
| Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer | NCT05628363 | Prostate Cancer Cancer of the P... | Ethos Varian tr... Adaptive stereo... Androgen depriv... | 18 Years - | Washington University School of Medicine | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| Proton Boost in Prostate Cancer | NCT03564275 | Cancer of the P... | Proton Boost | 18 Years - | University of Cincinnati | |
| MRI/Ultrasound Fusion Guided Prostate Cryotherapy | NCT02381990 | Neoplasms Prost... Cancer of the P... | FUSE IMAGE MRI ... | 55 Years - | Urological Research Network, LLC | |
| Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer | NCT02079025 | Prostatic Neopl... Prostate Cancer Cancer of the P... | High-resolution... Standard ultras... | 40 Years - 79 Years | Exact Imaging | |
| Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer | NCT03960788 | Cancer of the P... Castration-resi... | Gadoxetate Sodi... | 18 Years - | University of Cincinnati | |
| Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer | NCT02578940 | Cancer of the P... | 18F-Fluciclovin... | 18 Years - | Blue Earth Diagnostics | |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | NCT02564120 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | 35 Years - 80 Years | UNC Lineberger Comprehensive Cancer Center | ||
| Eligard Observational Registry for Patients With Prostate Cancer | NCT00992251 | Cancer of the P... | 18 Years - | CMX Research | ||
| PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training | NCT04057859 | Cancer of the P... | 18 Years - | CMX Research | ||
| MR-simulation in Radiotherapy for Prostate Cancer | NCT03238170 | Cancer of the P... | MRI scan | 18 Years - | Guy's and St Thomas' NHS Foundation Trust | |
| Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy | NCT00241475 | Prostate Cancer | Gefitinib | 18 Years - | AstraZeneca | |
| CyberKnife Radiosurgery for Localized Prostatic Carcinoma | NCT01045148 | Prostate Cancer | CyberKnife Radi... CyberKnife Radi... | 18 Years - | CyberKnife Centers of San Diego | |
| Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer | NCT02334579 | Prostate Cancer Prostatic Cance... Prostate Neopla... Prostatic Neopl... Cancer of the P... | CyberKnife Ster... | 18 Years - | Swedish Medical Center | |
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| CyberKnife Radiosurgery for Localized Prostatic Carcinoma | NCT01045148 | Prostate Cancer | CyberKnife Radi... CyberKnife Radi... | 18 Years - | CyberKnife Centers of San Diego | |
| A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer | NCT03392428 | Cancer of the P... Metastatic Canc... | 177Lu-PSMA617 Cabazitaxel | 18 Years - | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | |
| European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up | NCT04017325 | Cancer of the P... | no intervention... | 18 Years - | Steba Biotech S.A. | |
| PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training | NCT04057859 | Cancer of the P... | 18 Years - | CMX Research | ||
| Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer | NCT00417274 | Prostatic Cance... | Quinacrine | 18 Years - | Cleveland BioLabs | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Decision Impact Trial of the ExoDx Prostate (IntelliScore) | NCT03235687 | Cancer of the P... | ExoDx Prostate ... | 50 Years - | Exosome Diagnostics, Inc. | |
| Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate | NCT00915122 | Adenocarcinoma ... | Dose Escalated ... | - 80 Years | University Health Network, Toronto | |
| MRI/Ultrasound Fusion Guided Prostate Cryotherapy | NCT02381990 | Neoplasms Prost... Cancer of the P... | FUSE IMAGE MRI ... | 55 Years - | Urological Research Network, LLC | |
| CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry | NCT00643617 | Prostate Cancer Prostatic Cance... Prostatic Neopl... Prostate Neopla... Cancer of the P... | CyberKnife Ster... CyberKnife Ster... | 18 Years - | Accuray Incorporated | |
| A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | NCT00134706 | Prostate Cancer | Docetaxel Carboplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer | NCT01897207 | Cancer of the P... | Dendritic cell ... | 18 Years - | Cantonal Hospital of St. Gallen | |
| Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone | NCT02640534 | Cancer of the P... Prostate Cancer | Enzalutamide Metformin | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors | NCT02957357 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | - | Alliance Foundation Trials, LLC. | ||
| A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC) | NCT02384382 | Prostate Carcin... Castration Resi... | Enzalutamide | 18 Years - | Pfizer | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences | |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | NCT02349139 | Cancer of the P... Neoplasms, Pros... Prostate Cancer Prostatic Cance... Neoplasms, Pros... Prostate Neopla... | ASN001: Escalat... | 18 Years - | Asana BioSciences | |
| Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer | NCT01303705 | Metastatic Pros... Cancer of the P... Prostate Cancer | Anti-OX40 Radiation Cyclophosphamid... | 18 Years - | Providence Health & Services |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
